Standard BioTools Reports Second Quarter 2026 Financial Results

Go back to Standard BioTools Reports Second Quarter 2026 Financial Results
Labranche & Co (NASDAQ: LAB) Delayed: 0.74 --0 (-0%)
Previous Close $0.74    52 Week High $4.47 
Open $0.74    52 Week Low $3.02 
Day High $0.74    P/E N/A 
Day Low $0.74    EPS $-1.56 
Volume 22